DOI QR코드

DOI QR Code

Single-Dose Intramuscular Toxicity Study of SU-Eohyeol Pharmacopuncture in Rats

  • Hwang, Ji Hye (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University) ;
  • Ku, Jaseung (Bogwang Korean Medicine Clinic) ;
  • Jung, Chul (Namsangcheon Korean Medicine Clinic)
  • Received : 2022.04.23
  • Accepted : 2022.06.16
  • Published : 2022.09.30

Abstract

Objectives: This toxicological study was performed to assess for potential toxicity and to determine the approximate lethal dose of SU-Eohyeol pharmacopuncture (SUEP) following a single intramuscular injection of SUEP into male and female Sprague-Dawley (SD) rats. Methods: The groups in our experiment consisted of an experimental group treated with SUEP at a dose of 1.0 mL/animal and a control group injected with a normal saline solution, and five male and female rats were placed in each group. Each animal was administered a single intramuscular injection. We monitored all rats for clinical signs and body weight changes for 14 days after administration. At the end of the observation period, the rats were euthanized and autopsied, and localized tolerance examinations were conducted at the site of administration of the test substance. Results: There were no deaths in either sex in the SUEP-treated group. There was no significant difference between the SUEP-treated group and the control group in the clinical signs and weight changes among the rats. In addition, no significant SUEP-related changes were observed on autopsy findings or local tolerance examinations at the injection site by histopathological examination. Conclusion: Our results suggest that the approximate lethal dose of a single intramuscular administration of SUEP in female and male rats under the conditions of this study is greater than 1.0 mL/animal. To determine the safety of the use of SUEP in Korean medical clinical practice, additional toxicity studies will be needed.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. NRF-2022R1A2C1013518).

References

  1. Jung C, Jung JH, Lee MS. A clinical study of immune pharmacopuncturology. Yeongi: Kyungrak Medical Publishing Co.; 2011. 127-33 p.
  2. Korean Acupuncture and Moxibustion Society. Acupuncture medicine. Seoul: Hanmi Medical Publishing Co.; 2020. 204-28 p.
  3. Park J, Lee H, Shin BC, Lee MS, Kim B, Kim JI. Pharmacopuncture in Korea: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2016;2016:4683121.
  4. Park JE, Kim KH, Kang S, Lee EK, Kim JC, Jang BH, et al. Usage status and satisfaction with pharmacopuncture in Korea: a survey among Korean medicine doctors. Eur J Integr Med. 2019;27:121-30. https://doi.org/10.1016/j.eujim.2019.03.001
  5. Korean Pharmacopuncture Institute Science Committee, Pharmacopuncturology Institute. Pharmacopuncturology. 2nd ed. Seoul: Elsevier Korea; 2008. 3-8, 163-80, 259-420 p.
  6. Yun JM, Hur NY, Kim KH. The analysis of Korean clinical studies on the effect of pharmacopuncture for whiplash injury after traffic accidents. J Pharmacopuncture. 2020;23(4):262-72. https://doi.org/10.3831/KPI.2020.23.4.262
  7. Lee DJ, Hwangbo M, Kwon K, Seo HS. Review of cervi cornu parvum pharmacopuncture in korean medicine. J Pharmacopuncture. 2013;16(2):7-14.
  8. Bensky D, Gamble A. Chinese herbal medicine: materia medica. Revised ed. Seattle: Eastland Press; 1993. 32-44 p.
  9. Wu F, Li H, Jin L, Li X, Ma Y, You J, et al. Deer antler base as a traditional Chinese medicine: a review of its traditional uses, chemistry and pharmacology. J Ethnopharmacol. 2013;145(2):403-15. https://doi.org/10.1016/j.jep.2012.12.008
  10. Yoon JW, Kim SJ. A review of clinical study on Jungsongouhyul pharmacopuncture treatment published in Korea. J Korean Med Rehabil. 2017;27(4):75-84. https://doi.org/10.18325/jkmr.2017.27.4.75
  11. Ryu HS, Kim SP, Chun HS, Ryu MS, Shin JC, Wei TS. The comparative study of effects between acupuncture treatment and cotreatment with mixed pharmacopuncture of Jungsongouhyul and Cervi Pantotrichum Cornu on low back pain patients. J Korean Acupunct Moxib Soc. 2011;28(6):149-57.
  12. Xu Z, Kang Q, Yu Z, Tian L, Zhang J, Wang T. Research on the species difference of the hepatotoxicity of medicine based on transcriptome. Front Pharmacol. 2021;12:647084. https://doi.org/10.3389/fphar.2021.647084
  13. Ministry of Food and Drug Safety. Good Laboratory Practice Regulation for Nonclinical Laboratory Studies (Notification No. 2018-93) [Internet]. Cheongju: Ministry of Food and Drug Safety; 2018 Nov 21 [cited 2018 Nov 21]. Available from: https://www.law.go.kr/LSW/admRulLsInfoP.do?admRulSeq=2100000170349.
  14. Organisation for Economic Co-operation and Development (OECD). ENV/MC/CHEM(98)17: OECD series on principles of good laboratory practice and compliance monitoring number 1. Paris: OECD; 1998. 41 p.
  15. Sung SH, Shin BC, Park MJ, Kim KH, Kim JW, Ryu JY, et al. Current status of management on pharmacopuncture in Korea through introduction of an accreditation system. J Pharmacopuncture. 2019;22(2):75-82. https://doi.org/10.3831/KPI.2019.22.009
  16. Ministry of Health and Welfare. Guideline on Installation and Utilization of External Herbal Dispensaries of Traditional Korean Medicine Clinics and Share-use of Herbal Dispensaries [Internet]. Sejong: Ministry of Health and Welfare; 2017 Nov 6 [cited 2018 Nov 21]. Available from: http://www.mohw.go.kr/react/jb/sjb0406vw.jsp?PAR_MENU_ID=03&MENU_ID=030406&CONT_SEQ=342727&page=1.
  17. Ministry of Health and Welfare. Introduction of External Herbal Dispensaries of Traditional Korean Medicine Clinics [Internet]. Sejong: Ministry of Health and Welfare; 2018 May 23 [updated 2019 Nov 19; cited 2018 Nov 21]. Available from: http://www.mohw.go.kr/react/al/sal0301vw.jsp?PAR_MENU_ID=04&MENU_ID=0403&page=1&CONT_SEQ=344877&SEARCHKEY=TITLE&SEARCHVALUE=%ED%95%9C%EC%95%BD.
  18. Ministry of Food and Drug Safety. Good Laboratory Practice (GLP) [Internet]. Cheongju: Ministry of Food and Drug Safety; 2017 [cited 2022 Apr 1]. Available from: https://www.law.go.kr/LSW/admRulInfoP.do?admRulSeq=2100000086689.
  19. Ministry of Food and Drug Safety. Partial amendment official announcement about toxicity test for drug. Cheongju: Ministry of Food and Drug Safety; 2015.
  20. Lee MY, Seo CS, Kim JY, Shin HK. Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test. BMC Complement Altern Med. 2014;14:215. https://doi.org/10.1186/1472-6882-14-215
  21. Sung H, Lee E. Single-dose intramuscular toxicity of Mahwangcheonoh pharmacopuncture in a rat model: toxicity of Mahwangcheonoh Pharmacopuncture in SD rats. J Pharmacopuncture. 2016;19(4):336-43. https://doi.org/10.3831/KPI.2016.19.035
  22. Hwang JH, Ku J, Jung C. Evaluation of the single-dose toxicity of capsaicin pharmacopuncture in rats. J Acupunct Res. 2020;37(3):167-72. https://doi.org/10.13045/jar.2020.00185
  23. Rousseaux CG, Bracken WM. Overview of Drug Development. In: Haschek WM, Rousseaux CG, Wallig MA, editors. Haschek and Rousseaux's handbook of toxicologic pathology. 3rd ed. London: Academic Press; 2013. p. 647-685.
  24. Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, et al. Report from the in vitro micronucleus assay working group. Mutat Res. 2003;540(2):153-63. https://doi.org/10.1016/j.mrgentox.2003.07.005